Tuesday, May 13, 2025
Kelly Lees
Join us for a panel discussion from leaders in the world of women’s health, followed by networking and drinks.
Expert guests: Dr Helen O'Neill (CEO/Founder of Hertility), Dr. Anna Klepchukova (Chief Medical Officer at Flo Health) and Lina Chan WG ‘09 (Director of Women's Health at Holland & Barrett) will speak on the following topics:
- What women's health issues are being discussed today that were completely overlooked 10–15 years ago?
- How are these issues being addressed through innovations and research?
Dr Erin Hartman (Penn ‘18 / Global Health Scientist) will moderate the panel discussion.
Spaces will be limited so book now!
Panelist Biographies
Lina Chan
Lina Chan is the Director of Women’s Health at Holland and Barrett. Previously she was the CEO and co-founder of Parla. Lina spent most of her career working as a private equity investor in the US and the UK. After experiencing multiple pregnancy losses, difficulty conceiving and preterm birth, Lina became acutely aware of the gaps in women’s health care. She founded Parla in 2018 with the mission to improve women’s access to expert support and health education. She quickly grew the company to serve thousands of women before being acquired by Holland & Barrett, Europe’s largest health and wellness retailer, in 2022. Lina believes that women's health care should address the physical as well as mental health needs across a women's reproductive life-span. She is passionate about women’s health and entrepreneurship leading her to support a wave of new women in the space. Lina is also a regular public speaker advocating for women’s health issues at various events like GIANT Health, VivaTek, HIMSS Health and Femtechnology Summit. Born in Brazil, Lina lives in London with her husband and 3 children.
Dr Helen O’Neill
Dr Helen O’Neill is a Tenured Associate Professor in Reproductive and Molecular Genetics at University College London (UCL). Dr O’Neill has an honours degree in Genetics, an MSc in Prenatal Genetics and Fetal Medicine from UCL and did her PhD and postdoctoral research on the genetics of ovarian development in the Department of Stem Cell Biology and Developmental Genetics at the National Institute for Medical Research, London. She lectures both masters and medical students and is active in research and public engagement involving genome editing and preimplantation embryo development. Dr O’Neill(MSc, PhD) is also the CEO and Founder of Hertility, an award-winning women’s health company shaping the future of reproductive healthcare by pioneering unique diagnostic testing that provides data-driven and advanced insights into reproductive health, fertility decline and the onset of menopause. Hertility provides end-to-end gynaecology care from testing to treatment and was featured in Forbes as one of ten companies with world-changing potential.
As a thought leader in reproductive science, she is a TedX speaker, has been interviewed frequently on the BBC, BBC World News, Sky News, the Guardian and was awarded in the Top Twenty Women in Data, 2019 as well as Top 50 Women in European Tech by the Financial Times.
Dr Anna Klepchukova
Dr. Anna Klepchukova is Chief Medical Officer at Flo Health, where she blends clinical expertise and pharmaceutical marketing experience to advance women’s health. Since joining Flo in 2017, Anna has played a pivotal role in its rise to the world’s #1 women’s health app. She built Flo’s Medical and Science team and established its Advisory Boards, now featuring 120+ global experts. These teams ensure Flo meets top medical standards and integrates the latest science, earning it the #1 OB-GYN-recommended app for period and cycle tracking.
Trained as a physician, Anna began her career in intensive care, where she developed a deep interest in preventative care. This passion led her to the pharmaceutical industry, including a role at Takeda Pharmaceuticals, where she witnessed the lack of innovation in female health. That gap—and her desire to disrupt it—brought her to Flo.
Anna holds an MD from Belarusian State Medical University and studied marketing at The Chartered Institute of Marketing in the UK. Currently, she’s pursuing an Executive Diploma in AI for Business at Oxford. Her mission is to harness science and technology to transform reproductive and sexual health, empowering women and people who menstruate to live healthier, happier lives.
Moderator
Erin Hartman
A 2018 Penn grad, Erin Hartman is a nurse, public health researcher, and Marshall Scholar with a background in clinical care, health systems strengthening, and public policy. She began her career as a registered nurse and sexual assault forensic examiner in New York City before moving to the UK to pursue postgraduate studies in international human rights law and public health. Erin recently completed her PhD at the London School of Hygiene & Tropical Medicine, where her research focused on sexual and reproductive health of girls and young women in Kenya's North Rift Valley. She has worked with WHO and PAHO to strengthen data, policy, and innovation in response to violence against women and girls around the world.
